Tenaxis Medical develops and markets high-performance sealants and anti-adhesion agents to meet unmet needs in the vascular and general surgery fields. The company’s state-of-the-art products are based on proprietary technologies developed by Tenaxis Medical.
ArterX™ Vascular Sealant
A unique prophylactic sealant that seals immediately upon clamp release. 1
ArterX™ Vascular Sealant is a novel prophylactic agent that seals anastomotic suture lines in seconds. The sealant quickly sets into a soft gel that contains a unique cross-linking agent to provide strong covalent bonding between tissues and to effectively seal grafts.
ArterX™ Self-Mixing Syringe: The sealant’s two components are mixed and applied using a self-mixing syringe that provides easy, precise placement of the sealant.
Benefits:
• Gels in seconds
• Flexible and durable sealing (strong covalent bonding)
• Noninflammatory tissue response, similar to sutures
• Bioresorbable
• Works in dry fields and in the presence of blood.
• No mixing required - self-mixing syringe provides accurate placement
• Simple to apply
• Excess sealant easily removed from instruments and surrounding tissue
• No product-related adverse events or safety issues identified in preliminary clinical trials
1. Stone WM, Fleming M, Fowl RJ, Florek HJ. Multicentral trial of a novel vascular sealant. Poster presented at the Society for Clinical Vascular Surgery, 36th Annual Symposium, March 5-8, 2008, Las Vegas, Nevada.
ArterX is CE marked for sale for its intended purpose as a medical device within the European Union. ArterX is not approved for use or sale in the United States.